Review Article

Cross-Talk between Oxidative Stress and m6A RNA Methylation in Cancer

Table 2

Effects of oxidative stress in cancers.

Cancer typeGene involvedFunction of ROSDescriptionReferences

Acute myeloid leukemiaTIGARTumor suppressorKnockdown of TIGAR promoting ROS-mediated apoptosis and antiproliferation[311]
NOXTumor promoterActivation of NOX increases extracellular ROS level promoting the proliferation of acute myeloid leukemia blasts[312]
Breast cancerp53Tumor suppressorp53 activation induced by ROS can promote necrosis and apoptosis of cancer cells[313]
SOD2Tumor promoterUpregulation of SOD2 induces elevated ROS to sustain AMPK-activated signal to promote aerobic glycolysis and malignant transformation[314]
ZEB1; GPX4Tumor promoterZEB1 inhibits transcription of GPX4, increases ROS accumulation and EMT, which promote breast cancer progression[315]
Colorectal cancerHIF-2αTumor suppressorActivated HIF-2α induces ROS production by an iron-dependent pathway which led colorectal cancer cell death[316]
ANGPTL4; NOX4Tumor promoterANGPTL4/NOX4 axis maintains the metastatic ability of colorectal cancer cells via increasing ROS, MMP1, and MMP9 levels[317]
GlioblastomaPRDX3Tumor suppressorProhibitin maintains the stability of PRDX3 to reduce the production of ROS, maintain glioblastoma stemness and promote the resistance of gliomas stem-like cells to radiotherapy[318]
TRAP1; SIRT3Tumor suppressorTRAP1 cooperate with SIRT3 to reduce ROS production and promotes stress adaptation of glioblastoma cancer stem cells[319]
Gastric cancerNNTTumor suppressorNNT deficiency can significantly reduce NADPH and significantly induce ROS production and apoptosis under stress.[320]
GRIM-19; Nrf2Tumor promoterGRIM-19 deficiency accelerates gastric cancer metastasis via abnormal oxidative stress and ROS-driven Nrf2 activation[321]
Hepatocellular carcinomaUBQLN1; PGC1βTumor suppressorElevated expression of UBQLN1 induces PGC1β degradation to promote sorafenib resistance of hepatocellular carcinoma cells by reducing mitochondrial ROS production[322]
PKCλ/ι; Nrf2Tumor promoterLoss of PKCλ/ι induces ROS generation promoting hepatocellular carcinoma in a Nrf2-dependent manner[323]
Lung cancerIL-15; mTORTumor promoterNK cells activate thioredoxin system through IL-15/mTOR axis to adapt to high ROS level in tumor microenvironment[324]
AK4; HIF-1αTumor promoterUpregulation of AK4 enhances expression of HIF-1α through increasing ROS production, and then EMT was induced in hypoxia condition[325]
AIM2; MAPK/ERK; MFN2Tumor promoterKnockdown of AIM2 upregulates MFN2 and enhances the mitochondrial fusion, resulting in the reduction of mitochondrial ROS production, which in turn induces the inactivation of the MAPK/ERK pathway and hinders the progress of non-small cell lung cancer[326]
Nestin; Keap1; Nrf2;Tumor suppressorNestin competed with Nrf2 for binding to Keap1, leading to Nrf2 escape and downstream antioxidant gene expression, which promotes the resistance of NSCLC to oxidative stress[327]
MelanomaANGPT2Tumor suppressorSilence of Angpt2 expression significantly increases the level of intracellular ROS and activation of downstream MAPK pathway, thus resulting in the metastatic colonization of melanoma[328]
AktTumor promoterAkt overexpression can induce the expression of NOX4, increase the level of ROS, increase the expression of VEGF, increase angiogenesis, and promote the aerobic glycolysis of melanoma cells[329]
Ovarian cancerRAD51Tumor promoterLoss of RAD51 accelerates mitochondrial ROS accumulation and DNA damage which can be weakened by treatment of antioxidant N-acetylcysteine[330]
Pancreas cancerUCP2; Akt; mTORTumor suppressorInhibition of UCP2 plays an anticarcinogenic role in pancreatic adenocarcinoma cells via activating ROS/Akt/mTOR axis[331]
Renal cell carcinomaTAZ; EMP1; NOX4;Tumor suppressorNuclear translocation of TAZ upregulates EMP1 expression, thereby increasing the mRNA level of NOX4 and inducing ferroptosis of renal cell carcinoma cells via elevated lipid ROS[332]